M0N

(1-HYDROXY-2-IMIDAZO[1,2-A]PYRIDIN-3-YLETHANE-1,1-DIYL)BIS(PHOSPHONIC ACID)

Find entries where: M0N

is present as a standalone ligand in 5 entries

Find related ligands:

Chemical Component Summary
Name	(1-HYDROXY-2-IMIDAZO[1,2-A]PYRIDIN-3-YLETHANE-1,1-DIYL)BIS(PHOSPHONIC ACID)
Synonyms	MINODRONATE; 1-HYDROXY-2-(5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDIN-3-YL)ETHANE-1,1-DIYLDIPHOSPONIC ACID; (1-HYDROXY-2-IMIDAZO[1,2-A]PYRIDIN-3-YL-ETHYLIDENE)-1,1-BISPHOSPHONIC ACID
Identifiers	(1-hydroxy-2-imidazo[3,2-a]pyridin-3-yl-1-phosphono-ethyl)phosphonic acid
Formula	C₉ H₁₂ N₂ O₇ P₂
Molecular Weight	322.148
Type	NON-POLYMER
Isomeric SMILES	c1ccn2c(c1)ncc2CC(O)(P(=O)(O)O)P(=O)(O)O
InChI	InChI=1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18)
InChIKey	VMMKGHQPQIEGSQ-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	32
Chiral Atom Count	0
Bond Count	33
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB06548
Name	Minodronic acid
Groups	investigational
Synonyms	Minodronic acid Minodronate
Indication	Investigated for use/treatment in multiple myeloma, breast cancer, osteoporosis, and lung cancer.
Categories	Organophosphonates Organophosphorus Compounds
CAS number	180064-38-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Farnesyl pyrophosphate synthase	MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCW...	unknown	inhibitor
Geranylgeranyl pyrophosphate synthase	MEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIII...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682